Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Decoy Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Decoy Therapeutics Inc. July 14, 202684.1%
-
Decoy Therapeutics Inc. June 14, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Rallybio Corporation | Option exercise | +7,124 | $14.88 | $106,005 |
| Oct 29, 2026 | Rallybio Corporation | Option exercise | +7,875 | $14.88 | $117,180 |
| Oct 29, 2026 | Rallybio Corporation | Option exercise | +13,589 | $6.08 | $82,621 |
| Oct 27, 2026 | Rallybio Corporation | Open-market sale | −599 | $16.04 | $9,608 |
| Oct 26, 2026 | Rallybio Corporation | Grant or award | +2,500 | — | — |
| Oct 9, 2026 | Rallybio Corporation | Option exercise | +3,910 | $6.08 | $23,773 |
| Sep 29, 2026 | Rallybio Corporation | Option exercise | +5,000 | $6.08 | $30,400 |
| Aug 31, 2026 | Decoy Therapeutics Inc. | Grant or award | +2,000 | — | — |
| Feb 23, 2026 | Rallybio Corporation | Open-market sale | −789 | $5.06 | $3,992 |
| Feb 18, 2026 | Rallybio Corporation | Grant or award | +2,500 | — | — |
| Mar 14, 2023 | Rallybio Corporation | Open-market purchase | +5,000 | $5.21 | $26,050 |
| Jan 3, 2023 | Decoy Therapeutics Inc. | Grant or award | +1,440 | — | — |
Questions about Jonathan I. Lieber
What boards is Jonathan I. Lieber on?
Jonathan I. Lieber sits on the board of Decoy Therapeutics Inc.
How long has Jonathan I. Lieber served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.